A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker
Clinical trial NCT06156527 · RECRUITING
Trial details
- NCT number
- NCT06156527
- Sponsor
- National Cancer Center, Korea
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-05
- Primary completion
- 2026-09-05
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.